Biotech · Public company · New York, NY, US
SELLAS Life Sciences Group, Inc.
Ticker SLS · SEC CIK 0001390478
Track this companyFree. Adds SELLAS Life Sciences Group, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline22
- AzacitidinePhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CytarabinePhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DecitabinePhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Galinpepimut-SPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- ObservationPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- azacitidinePhase 2 · Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- bortezomibPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- galinpepimut-SPhase 2 · Acute Myelogenous LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Galinpepimut-SPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Galinpepimut-S + Montanide + GM-CSFPhase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- GM-CSFPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- GM-CSFPhase 2 · Acute Myelogenous LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- GM-CSFPhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- lenalidomidePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- MontanidePhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- MontanidePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- MontanidePhase 2 · Acute Myelogenous LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Montanide + GM-CSFPhase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 2 · Acute Myelogenous LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- SLS009Phase 2 · Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- venetoclaxPhase 2 · Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLPHASE1_PHASE2 · RECRUITING · started May 10, 2021ClinicalTrials.gov NCT04588922 · fetched Nov 12, 2026
- Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2PHASE3 · ACTIVE_NOT_RECRUITING · started Feb 8, 2021ClinicalTrials.gov NCT04229979 · fetched Nov 12, 2026
- Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersPHASE1_PHASE2 · COMPLETED · started Sep 30, 2019ClinicalTrials.gov NCT03761914 · fetched Nov 12, 2026
- Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer PatientsPHASE2 · COMPLETED · started Oct 1, 2014ClinicalTrials.gov NCT02297698 · fetched Nov 12, 2026
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVaxPHASE2 · COMPLETED · started May 21, 2013ClinicalTrials.gov NCT01570036 · fetched Nov 12, 2026
- WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell TransplantationPHASE1_PHASE2 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT01827137 · fetched Nov 12, 2026
- WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)PHASE2 · COMPLETED · started Jan 14, 2011ClinicalTrials.gov NCT01266083 · fetched Nov 12, 2026
- Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapyPHASE2 · COMPLETED · started Dec 21, 2010ClinicalTrials.gov NCT01265433 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 8, 2026 · fetched Nov 12, 2026